Brian Laegeler of Morningstar is predicting a boom in generic drugs once Obama is settled in the White House. The president-elect’s plans to increase insurance coverage and generic drug utilization, as well as a legislative pathway for generic biologics, paint a rosy picture for generics. Nearly $20 billion in branded drug sales are up for grabs when patent protections expire between 2009 and 2012. That could spark a price war come 2013.
Don’t forget you can visit MyAlerts to manage your alerts at any time.